Invex Therapeutics Ltd. (AU:IXC) has released an update.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Invex Therapeutics Ltd. has announced the cessation of 50,000 options due to the lapse of conditions that were not or could not be satisfied, effective June 28, 2024. The options, identified by the ASX security code IXCAI and expiring on December 1, 2026, were worth $0.68 each.
For further insights into AU:IXC stock, check out TipRanks’ Stock Analysis page.